Diagnosis and Surgical Management of Renal Tumors (Record no. 5016)

MARC details
000 -LEADER
fixed length control field 03597nam a22002537a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240305192333.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220216b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 3319923099
International Standard Book Number 9783319923093
040 ## - CATALOGING SOURCE
Transcribing agency Data centre
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Michael A. Gorin
9 (RLIN) 31357
245 ## - TITLE STATEMENT
Title Diagnosis and Surgical Management of Renal Tumors
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. The James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins University School of Medic Baltimore, MD USA
Name of publisher, distributor, etc. Springer
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 319 pages
520 ## - SUMMARY, ETC.
Summary, etc. Renal cell carcinoma (RCC) is the most common primary malignancy of the kidney, with an estimated 64,000 new cases diagnosed each year in the United States. Worldwide, this figure approaches 270,000 annual incident cases. At the time of initial presentation, 80% of patients with RCC will be diagnosed with a tumor localized the kidney. The majority of these lesions will be small (i.e. ≤4 cm) and potentially curable with either partial or radical nephrectomy. In recent decades, the rate of incidentally detected small renal tumors has risen substantially due the increasing use of cross-sectional imaging performed across the field of medicine. This rise in the incident number of localized renal tumors has unfortunately not resulted in a corresponding decrease in cases of metastatic RCC. This observation has led to our understanding that a significant proportion of incidentally detected renal tumors are of low malignant potential and may be safely managed with alternatives to surgery such active surveillance and thermo ablation. The use of these less invasive management approaches, however, must be balanced by the reality that upon spreading beyond the confines of the kidney, RCC is almost always incurable. Thus, when selecting a management strategy for a given patient, one must employ a risk-adapted approach that includes knowledge of a tumor’s histology and metastatic potential. In each patient, the goal of management should be to minimize the risk of progression to metastatic disease while preserving renal function and minimizing morbidity.<br/>This text provides a contemporary review of the diagnosis and surgical management of RCC. It opens with chapters on the pathology, radiology, and genetics of RCC. It then covers the risk stratification of renal tumors utilizing renal mass biopsy as well as non-invasive novel imaging-based scoring systems. Next, the surgical management of small and locally advanced renal tumors as well as the role of surgery in cases of metastatic RCC is reviewed. In addition, alternative approaches to surgery including active surveillance and ablative techniques are reviewed. Other chapters detail the emerging role of neoadjuvant and adjuvant systemic therapy in patients who are at high risk of progression to metastatic disease. Finally, the text covers the post-operative surveillance of patients with RCC as well as a summary of contemporary guidelines on the management of this disease.<br/>Diagnosis and Surgical Management of Renal Cell Carcinoma will serve as a comprehensive resource for physicians and researchers interested in RCC. All chapters will be written by experts in the field and will include the most up to date scientific and clinical information.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Medical / Urology
9 (RLIN) 27046
General subdivision Medical / Pathology
9 (RLIN) 27023
General subdivision Medical / Oncology / General
9 (RLIN) 26891
General subdivision Medical / Clinical Medicine
9 (RLIN) 26816
General subdivision Medical › Oncology › General
9 (RLIN) 26780
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 31358
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   02/16/2022   EBS9491 02/16/2022 02/16/2022 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024